Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CVRx Inc.
CVRX | US
5.39
USD-0.04
-0.74%
CVRX | US
About CVRx Inc.
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
03/06/2026
Close
5.39
Open
5.47
High
5.58
Low
5.33
CVRx Inc. a commercial-stage medical device company focuses on developing manufacturing and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force as well as sales agents and independent distributors in the United States Germany and internationally. CVRx Inc. was incorporated in 2000 and is headquartered in Minneapolis Minnesota.
View LessCVRX | US
Risk
97.3
Sharpe
-0.29
Luna's Score
39/100
Recommendation
Sell
Luna says (CVRX | US)
What's Working
Strong Revenue Growth (> 10%)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
28.8%1 month
97.3%3 months
82.4%6 months
86.9%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.19
Debt to equity
0.55
Debt to assets
0.32
Ent. to EBITDA
-1.31
Ent. to rev.
3.08
PEG
-
Other Fundamentals
EBITDA
-54.86M
MarketCap
100.23M
MarketCap(USD)
100.23M
Div. yield
-
Op. margin
-118.35
Erngs. growth
-
Rev. growth
24.30
Ret. on equity
-74.91
Short ratio
9.37
Short perc.
14.90
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
1.12
Range1M
3.14
Range3M
4.84
Volumes: Market Activity
Rel. volume
0.77
Price X volume
1.53M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -1.31 | - | Cheaper |
| Ent. to Revenue | 3.08 | - | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 3.19 | 6.21 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 82.42 | - | Riskier |
| Debt to Equity | 0.55 | -145.53 | Expensive |
| Debt to Assets | 0.32 | 0.35 | Par |
| Market Cap | 100.23M | - | Emerging |
